Related Experiment Video
Updated: Sep 20, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
ACTC1 Variants Result in Isolated and Syndromic Cardiac Phenotypes
Yuri A Zarate1, Lina Abdelmoti2, Seungjae Oh2
1Division of Genetics and Metabolism, University of Kentucky, Lexington, Kentucky, USA.
Insights
Pathogenic variants in ACTC1 gene cause cardiac conditions. This study identifies new ACTC1 variants linked to cardiomyopathies and extracardiac features like facial dysmorphism and skeletal anomalies.
Area of Science:
- Genetics and Molecular Biology
- Cardiology
- Developmental Biology
Background:
- Pathogenic variants in ACTC1 are associated with various cardiomyopathies.
- The full spectrum of ACTC1-related phenotypes is not yet completely understood.
Purpose of the Study:
- To expand the known clinical and genetic spectrum of ACTC1 variants.
- To investigate the impact of novel ACTC1 variants on cardiac and extracardiac development.
Main Methods:
- Clinical evaluation of two individuals with novel ACTC1 variants.
- Protein structure analysis to assess variant impact on protein function.
- In vivo zebrafish model to validate pathogenicity and developmental effects.
Main Results:
- Two individuals with heterozygous ACTC1 variants (Gly57, Glu101) presented with hypertrophic and left ventricular noncompaction cardiomyopathies.
- Extracardiac features including facial dysmorphism, short stature, and skeletal anomalies were observed.
- Structural and zebrafish analyses confirmed variant pathogenicity and impact on cranial tissue development.
Conclusions:
- This study broadens the understanding of ACTC1-related disorders, highlighting significant clinical and molecular diversity.
- ACTC1 variants can lead to complex phenotypes involving both cardiac and extracardiac systems.
- Further research is warranted to fully elucidate the genotype-phenotype correlations in ACTC1-related diseases.
Abstract:
Individuals carrying pathogenic variants in ACTC1 present with several cardiac phenotypes, including hypertrophic cardiomyopathy, dilated cardiomyopathy, and left ventricular noncompaction cardiomyopathy. In the current work, we expand the clinical and genetic spectrum of phenotypes caused by ACTC1 genetic variants by describing two individuals with heterozygous variants involving residues Gly57 or Glu101. These individuals presented with facial dysmorphism, short stature, and skeletal anomalies in addition to hypertrophic and left ventricular noncompaction cardiomyopathies. Protein structure analysis showed these variants alter the ATP binding or putative protein-protein interactions, while in vivo zebrafish analysis validated the pathogenicity of these ACTC1 variants and their impact on the development of the cranial tissues. Combined with recent reports of other individuals with ACTC1 variants and extracardiac phenotypes, this study provides further evidence of the extensive molecular and clinical diversity related to ACTC1.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy

